Episode Details

Aureum Diagnostics is scaling up fast, moving into a larger facility at Maxim Park to launch commercial GMP manufacturing of its groundbreaking Ebios platform—critical for biosafety testing in next-gen therapies. Founded by Professor Damion Corrigan, the UK life sciences firm is now hiring across R&D, manufacturing, and QA as it secures Series A funding and ramps up supply for global clients. With a 10-year lease, this expansion marks a bold, long-term commitment to Scotland’s life sciences future, led by CEO Tessa Ogle.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/deaf797adc926970